Valuing an early-stage biotechnology investment as a rainbow option.

Detalhes bibliográficos
Publicado no:	Journal of Applied Corporate Finance V. 23, 1-4 (2011).
Autor principal:	Brous, Peter A.
Formato:	Artigo
Idioma:	English
Assuntos:	Biotechnology industry. Business valuation. Investments. Risk assessment. Securities prices.